125 related articles for article (PubMed ID: 12021274)
1. Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. ICPP is angiogenic via vascular endothelial growth factor receptor signalling.
Gasmi A; Bourcier C; Aloui Z; Srairi N; Marchetti S; Gimond C; Wedge SR; Hennequin L; Pouysségur J
J Biol Chem; 2002 Aug; 277(33):29992-8. PubMed ID: 12021274
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a growth factor-like which increases capillary permeability from Vipera lebetina venom.
Gasmi A; Abidi F; Srairi N; Oijatayer A; Karoui H; Elayeb M
Biochem Biophys Res Commun; 2000 Feb; 268(1):69-72. PubMed ID: 10652214
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper).
Komori Y; Nikai T; Taniguchi K; Masuda K; Sugihara H
Biochemistry; 1999 Sep; 38(36):11796-803. PubMed ID: 10512636
[TBL] [Abstract][Full Text] [Related]
4. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain.
Ogawa S; Oku A; Sawano A; Yamaguchi S; Yazaki Y; Shibuya M
J Biol Chem; 1998 Nov; 273(47):31273-82. PubMed ID: 9813035
[TBL] [Abstract][Full Text] [Related]
5. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF
J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on mitochondrial function.
Messadi E; Aloui Z; Belaidi E; Vincent MP; Couture-Lepetit E; Waeckel L; Decorps J; Bouby N; Gasmi A; Karoui H; Ovize M; Alhenc-Gelas F; Richer C
J Cardiovasc Pharmacol; 2014 Mar; 63(3):274-81. PubMed ID: 24220315
[TBL] [Abstract][Full Text] [Related]
7. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain.
Ruckman J; Green LS; Beeson J; Waugh S; Gillette WL; Henninger DD; Claesson-Welsh L; Janjić N
J Biol Chem; 1998 Aug; 273(32):20556-67. PubMed ID: 9685413
[TBL] [Abstract][Full Text] [Related]
8. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
9. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
[TBL] [Abstract][Full Text] [Related]
11. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
13. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.
Joukov V; Kumar V; Sorsa T; Arighi E; Weich H; Saksela O; Alitalo K
J Biol Chem; 1998 Mar; 273(12):6599-602. PubMed ID: 9506953
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel vascular endothelial growth factor (VEGF) with no affinity to heparin in Gloydius tsushimaensis venom.
Nakamura H; Murakami T; Imamura T; Toriba M; Chijiwa T; Ohno M; Oda-Ueda N
Toxicon; 2014 Aug; 86():107-15. PubMed ID: 24857790
[TBL] [Abstract][Full Text] [Related]
15. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.
Toivanen PI; Nieminen T; Laakkonen JP; Heikura T; Kaikkonen MU; Ylä-Herttuala S
Sci Rep; 2017 Jul; 7(1):5525. PubMed ID: 28717175
[TBL] [Abstract][Full Text] [Related]
16. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.
Zachary I; Gliki G
Cardiovasc Res; 2001 Feb; 49(3):568-81. PubMed ID: 11166270
[TBL] [Abstract][Full Text] [Related]
17. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
19. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
20. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
